SBI General Insurance has launched a new health insurance vertical, through which the company plans to focus on new innovative health products, in-house claim settlement process, and others, to boost customer experience.
Researchers at the Indian Institute of Science (IISc) Bangalore have designed a new class of artificial peptides or miniproteins that they say can render viruses like SARS-CoV-2 inactive.
EXAMIANS